187 related articles for article (PubMed ID: 18951537)
21. Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson's disease.
Coban A; Hanagasi HA; Karamursel S; Barlas O
Br J Neurosurg; 2009 Feb; 23(1):23-9. PubMed ID: 19234905
[TBL] [Abstract][Full Text] [Related]
22. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.
Rodriguez-Blazquez C; Rojo-Abuin JM; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Oct; 19(10):889-93. PubMed ID: 23791519
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study.
Tsai ST; Hung HY; Hsieh TC; Lin SH; Lin SZ; Chen SY
Clin Neurol Neurosurg; 2013 Oct; 115(10):2082-7. PubMed ID: 23916724
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
25. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
[TBL] [Abstract][Full Text] [Related]
26. [Medial posteroventral pallidotomy for the treatment of Parkinson's disease].
Krauss JK; Grossman RG; Lai EC; Schwartz K; Jankovic J
Zentralbl Neurochir; 1997; 58(4):153-62. PubMed ID: 9487651
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
Rabey JM; Bass H; Bonuccelli U; Brooks D; Klotz P; Korczyn AD; Kraus P; Martinez-Martin P; Morrish P; Van Sauten W; Van Hilten B
Clin Neuropharmacol; 1997 Aug; 20(4):322-37. PubMed ID: 9260730
[TBL] [Abstract][Full Text] [Related]
28. Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial.
Rascol O; Bronzova J; Hauser RA; Lang AE; Sampaio C; Theeuwes A; van de Witte SV
Parkinsonism Relat Disord; 2012 May; 18(4):370-6. PubMed ID: 22316635
[TBL] [Abstract][Full Text] [Related]
29. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature.
Ghika J; Ghika-Schmid F; Fankhauser H; Assal G; Vingerhoets F; Albanese A; Bogousslavsky J; Favre J
J Neurosurg; 1999 Aug; 91(2):313-21. PubMed ID: 10433321
[TBL] [Abstract][Full Text] [Related]
30. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
[TBL] [Abstract][Full Text] [Related]
31. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
Kovács N; Aschermann Z; Ács P; Bosnyák E; Deli G; Janszky J; Komoly S
Ideggyogy Sz; 2014 Jul; 67(7-8):245-50. PubMed ID: 25509365
[TBL] [Abstract][Full Text] [Related]
32. Comparison of patient rated treatment response with measured improvement in Parkinson's disease.
Davidson MB; McGhee DJ; Counsell CE
J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):1001-5. PubMed ID: 22626942
[TBL] [Abstract][Full Text] [Related]
33. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.
Goetz CG; Leurgans S; Raman R;
Mov Disord; 2002 Mar; 17(2):283-8. PubMed ID: 11921113
[TBL] [Abstract][Full Text] [Related]
34. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
[TBL] [Abstract][Full Text] [Related]
35. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
[TBL] [Abstract][Full Text] [Related]
36. The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.
Song J; Fisher BE; Petzinger G; Wu A; Gordon J; Salem GJ
Neurorehabil Neural Repair; 2009 Sep; 23(7):657-61. PubMed ID: 19336530
[TBL] [Abstract][Full Text] [Related]
37. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review.
Ghika J; Villemure JG; Fankhauser H; Favre J; Assal G; Ghika-Schmid F
J Neurosurg; 1998 Nov; 89(5):713-8. PubMed ID: 9817406
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.
Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O
JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938
[TBL] [Abstract][Full Text] [Related]
39. Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study.
Mizuno Y; Abe T; Hasegawa K; Kuno S; Kondo T; Yamamoto M; Nakashima M; Kanazawa I;
Mov Disord; 2007 Oct; 22(13):1860-5. PubMed ID: 17618525
[TBL] [Abstract][Full Text] [Related]
40. An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease.
Pinter MM; Rutgers AW; Hebenstreit E
J Neural Transm (Vienna); 2000; 107(11):1307-23. PubMed ID: 11145006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
